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Risk is an inherent aspect of our lives. Whether the topic is the nation's dietary habits, 
community air pollution or chemical exposures in the workplace, risk analysis is an integral 
part of the conversation.
Risk analysis is the combined activities of assessing, managing and communicating human 
health risks. Interest in understanding risk from chemical exposures and other stressors has 
led to the formalization of health risk assessment as an applied public health science. 
Numerous seminal reports from the National Academies of Science (NAS) have highlighted 
the framework for risk assessment and risk management, as well as key changes within the 
practice of risk analysis.
The profession of industrial hygiene has evolved to reflect the changes in health risk 
assessment methodology and practice. Traditional industrial hygiene practice−the 
anticipation, recognition, evaluation and control of occupational and environmental hazards 
and risks–parallels key aspects of health risk assessment. Thus, industrial hygienists have a 
strong history as leading practitioners of all aspects of risk analysis–health risk assessment, 
risk management and risk communication–within the occupational environment.
Risk analysis methods and tools are important resources for articulating scientific 
knowledge to those who make decisions regarding public and occupational health. Just as 
we need to stay attuned to developments in the latest air sampling techniques, keeping 
current on risk analysis is equally essential.
As the field of risk analysis expands, emerging techniques will be valuable for practicing 
industrial hygienists. Examples include:
• tools for addressing aggregate risk from single agents yet multiple environments 
(for example, work, home, car, air) and cumulative risks from multiple stressors
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• a more thorough incorporation of cost-benefit analysis and life cycle impacts on 
occupational exposures for a better understanding of the economic impacts of risk 
management decisions
• improved techniques for studying how perceptions affect the acceptability of a 
particular risk
Driven by advances in science and technology, these new risk analysis methods are allowing 
health professionals, including industrial hygienists, to tackle ever more complex problems 
and make more informed decisions. For industrial hygienists, this new era offers several 
opportunities. Mastery of risk analysis tools is one of our core competencies; staying ahead 
of the curve will serve occupational and public health well and increase our value.
With this vision in mind, AIHA sponsored the 8th Risk Assessment Symposium as part of 
the Professional Conference on Industrial Hygiene (PCIH) in Baltimore this past November. 
The Symposium highlighted innovations that are fundamentally changing the practices of 
risk assessment, risk management and risk communication.1 Speakers at the Symposium 
represented experts in the fields of industrial hygiene, toxicology, occupational health and 
risk assessment from academia, industry and the public sector.
Over the next few months, a series of articles in The Synergist will describe the key concepts 
presented during the Symposium. This article, the first in the series, identifies the main 
challenges facing industrial hygienists as we enter the new era of risk assessment.
Reducing Uncertainty
Uncertainty is inherent within a risk assessment.2 If a dangerous condition exists with little 
or no uncertainty, there is no reason to assess risk; one moves directly to controlling the 
hazards. Thus, risk assessments must consider uncertainty during every phase of the process.
Uncertainties exist in the identification and measurement of hazards, the estimation of 
exposures, the identification and measurement of health effects associated with exposures, 
and the method used to characterize population and operational risks. Creating a risk 
assessment is an iterative process designed to be refined until there is consensus on the most 
important and most uncertain factors affecting the results. How confident do decision 
makers need to be regarding these important but uncertain factors? The answer to this 
question should determine the duration and complexity of the risk assessment. Perceptions 
of risk and the availability of data influence estimates of health risk.
A major criticism of the risk assessment process concerns the impact of uncertainty on the 
accuracy and usability of the findings. Uncertainty can be thought of as absence of 
knowledge on a specific issue, such as the toxicity or physiochemical properties of a 
substance, or the distribution of exposures among a group of factory workers. One way to 
reduce the impact of uncertainty is to include data within each step of the risk assessment. 
The need for robust sources of scientific data is a challenge that must be overcome to ensure 
accurate, usable results.
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Fortunately, promising scientific advancements may help reduce uncertainty. For example, 
new toxicity testing methods under development might offer quicker and less expensive 
alternatives to traditional bioassays. A groundbreaking 2007 NAS report outlined a 
framework for the continued development and use of alternative testing methods that aligns 
with the traditional risk assessment paradigm3 and generates data needed to reduce 
uncertainty within the hazard identification and dose-response steps of a risk assessment. 
This information will help characterize chemicals' properties and metabolism, define key 
exposure pathways, and identify potential human effects of exposure. These new sources of 
data will greatly enhance industrial hygienists' ability to conduct effective occupational and 
environmental assessments. The challenge lies in understanding and applying the new data 
to reduce the impact of uncertainty within the risk assessment process.
Shifting from Traditional Health End Points
What health end point should serve as the focal point for an occupational risk assessment? 
Should transient reversible or subclinical health effects be regulated to the same level as 
irreversible effects, such as cancer?
These questions are frequently debated among health professionals, stakeholders and 
regulators. A review of the documentation of available occupational exposure limits (OELs) 
quickly demonstrates that a large majority of the health-based recommendations focus on 
irreversible health end points, such as cancer, neurotoxicity or reproductive effects. 
Advances in science and medicine now allow us to identify subclinical effects, such as 
genetic and immune responses to certain chemical agents, that have not been considered 
during the derivation of OELs. For example, consider the effects of enzymes that metabolize 
occupationally relevant toxicants. Many genes that code for these enzymes are 
polymorphic–that is, the genes vary from person to person, resulting in different responses. 
In theory, a subpopulation of workers might exhibit greater susceptibility to the toxic effects 
of a chemical and, therefore, require additional protection. In the case of dichloromethane, 
researchers have found that examining genetic data reduced the unit risk by a factor of more 
than 100 from previously published risk assessments. The degree to which genetic 
polymorphisms increase human variability in toxic response is widely discussed, but so far, 
such variability has been poorly characterized.
Genetic data may also prove useful in addressing uncertainties in cross-species and other 
extrapolations. It remains to be seen how useful the genetic data being accumulated now will 
be to 21st century risk assessment, but it's clear that integrating genetic information into risk 
assessment will be an exciting new challenge.
Another emerging practice, cumulative risk assessment, assesses the combined risks 
associated with multiple stressors on human health. This goes beyond determining the 
impact of exposures to a single agent via multiple pathways, such as inhalation, dermal and 
oral; it attempts to determine the role of numerous agents on the development of a disease.4 
Cumulative risk assessment shifts the attention for a single stressor, such as a chemical, to 
multiple stressors. Although industrial hygienists are familiar with the need to account for 
multiple exposure pathways, assessing multiple stressors is a new concept that poses 
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numerous challenges. For example, how do we control a specific hazard within the 
workplace when a cumulative risk assessment reveals that non occupational factors (for 
example, contaminated waters, prescription medication and dietary habits) are increasing the 
risks of health consequences for workers? Clearly, industrial hygienists need to consider 
nontraditional exposure scenarios with a focus on the pathways, sources and agents.
Emerging Hazards
Industrial hygienists are all too familiar with the challenges that arise when emerging 
technologies are introduced into the workplace. These novel hazards might stem from new 
molecules or processes, old molecules used in new ways or non chemical stressors.
The best example of new molecules that are impacting our world may be engineered 
nanomaterials, which in recent years have been integrated into an infinite number of 
commercially available products. The new molecules under development to comply with the 
need for sustainability are another example. The data available on the toxicity of these 
chemicals are often limited, and the health risks to humans are unknown. New uses of 
molecules traditionally identified as safe may result in hazardous conditions not previously 
characterized (flavoring compounds, for example). The last type of emerging hazards 
focuses on nonchemical stressors, such as shift work, which the International Agency for 
Research on Cancer recently identified as probably carcinogenic to humans based on 
disruption of the body's biological rhythms.5
What health risks do these emerging hazards pose to workers, the environment or 
consumers? How do industrial hygienists develop risk management policies to protect 
workers when limited data are available on these hazards? These questions aren't easy to 
answer.
Meeting the Challenge
Industrial hygienists are uniquely qualified to participate in the evolution of the risk 
assessment process due to the multidisciplinary nature of the profession and our long history 
as risk assessment professionals. And because of our training and education in the physical 
and biological sciences, public health, engineering and management, we have a perspective 
not shared by other, more specialized professions. We are therefore well placed to take the 
lead in developing methods of risk analysis (risk assessment, risk management and risk 
communication). A proactive stance will ensure that new technologies and approaches in the 
risk sciences can address the challenges posed by the occupational environment.
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